Title : Monoamine oxidase-B inhibition in the treatment of Parkinson's disease.

Pub. Date : 2007 Dec

PMID : 18041937






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The two available MAO-B inhibitors approved for use in the United States, rasagiline and selegiline, each provide symptomatic relief as monotherapy and as adjunctive therapy, and have shown potential disease-modifying effects in experimental models and clinical studies. rasagiline monoamine oxidase B Homo sapiens